BRZE enters its September 8 earnings print in an unusual bind: the stock is up 32% over the past month, analysts are rushing to lift targets, yet short sellers have quietly rebuilt a meaningful position in the rally.
The short interest story is the week's sharpest tension. Bears added aggressively — short interest jumped 25% over the week to 12.3% of the free float, the highest level in the 30-day window. That followed a sharp drop in late August, so the move looks like a deliberate re-short into strength rather than a slow bleed. At the same time, the borrow market remains remarkably relaxed. Availability is running at roughly 394% — meaning nearly four shares are available to lend for every one already borrowed — and cost to borrow is a negligible 0.53%. Bears are rebuilding, but they are doing so cheaply and easily, with no squeeze pressure in sight. Options traders are telling a different story entirely: the put/call ratio has collapsed to 0.17, nearly 1.2 standard deviations below its 20-day average and approaching the 52-week low of 0.14. That is an exceptionally call-heavy skew, suggesting the options market is positioned for more upside, not a reversal. The contrast is stark — short sellers are leaning bearish into earnings, while options participants are leaning decisively the other way.
The Street is broadly constructive, and Tuesday's post-earnings analyst response reinforced that. DA Davidson raised its target to $40 and Barclays lifted to $38, both maintaining positive ratings in the immediate aftermath of the most recent print on August 27. TD Cowen and Oppenheimer had already moved targets higher to $36 on the day of that release. The consensus is Buy, with 14 covering analysts, and the mean target of $36.25 sits only modestly above the current price of $32.78 — not a stretched bull case. The bull argument centres on AI decisioning product momentum, accelerating organic growth for three consecutive quarters, and improving gross retention. Bears push back on persistent unprofitability, consumer concentration in QSR and retail verticals, and the threat from AI-native competitors. Valuation has re-rated materially: the price-to-earnings multiple expanded roughly 7.5 points over 30 days, and EV/EBITDA rose 2.3 turns over the same period — the market is paying up for the growth acceleration narrative. EPS forward estimates have swung dramatically positive, ranking in the 90th percentile for 12-month forward year-on-year increase, which underpins the analyst optimism.
The institutional register flags one notable development. FMR (Fidelity) disclosed a 15% stake via a 13G/A filed on August 6, up from 12.4% previously — making it by far the largest holder at nearly 17 million shares. BlackRock lifted its position to 7.1% (from 6.1%) in a filing dated July 27. Vanguard Portfolio Management initiated a new 5%-plus stake as recently as July 31. These are passive and quasi-passive flows, but the directional accumulation from three large institutions into the rally is a meaningful support signal. On the insider side, the CTO and CRO both sold shares on August 24–27 under pre-arranged 10b5-1 plans — planned sales are far less informative than discretionary ones, but the net 90-day insider position is still a negative $2.6 million across roughly 82,000 shares. Worth noting, not alarming.
Recent earnings reactions have been sharply positive. The August 27 print moved the stock 12% on the day. The June 30 release produced a 9.3% next-day gain and a 16.4% five-day move. The prior two quarters were negative — a flat print in June and an 8.2% drop in late May — making the recent run a genuine reversal of trend rather than a continuation. The short score of 60.4 reflects the elevated short interest but is not at the extreme end of the range. Peers DOCU and CRM both gained roughly 6-7% on the week, broadly in line with BRZE's 6.4% move, while CXM lagged at under 2%.
The next session to watch is September 8, when the company reports again. With bears rebuilding short positions at 12% of float, calls dominating the options market, and three large institutions having recently added, the setup heading into that print is anything but consensus — how the stock reacts will test which side of that divide is reading the room correctly.
See the live data behind this article on ORTEX.
Open BRZE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
